Pembrolizumab Plus SBRT Fails to Improve Survival in Unresected Stage I/II NSCLC
The addition of pembrolizumab to radiation did not improve survival in unresected, stage I or II non–small cell lung cancer.
Related Articles
Anito-Cel Demonstrates Safety and Early Efficacy in R/R Multiple Myeloma
Anitocabtagene autoleucel generated durable response in patients with relapsed/refractory multiple myeloma.
Call-for-Papers | JACC: CardioOncology
Submission Deadline: February 15, 2025 Cardio-oncology historically has focused on the cardiotoxic effects of cancer therapies; however, as our field continues to evolve, there is…
Iparomlimab/Tuvonralimab Plus Chemo ± Bevacizumab Yields Responses in Recurrent/Metastatic Cervical Cancer
First-line paromlimab/tuvonralimab plus chemotherapy with or without bevacizumab was active in recurrent/metastatic cervical cancer.
NewsDetails
Rachel Darwin, Senior Manager, Public Relations Free information from the National Comprehensive Cancer Network offers information on how and why to access genetic counseling and…
Upcoming Insights – Strategies for Management of Dermatological Reactions from Combination Amivantamab/ Lazertinib for EGFR-mutated NSCLC
Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy for oncologists treating patients in a community setting.
Dr Nathanson on BRCA1/2 Reversion Mutations in Response to Therapy in Breast Cancer
Katherine L. Nathanson, MD, discusses the identification of reversion mutations in BRCA1/2 in response to therapy among patients with breast cancer.
Navigating Between Front-line Systemic Therapies in uHCC.
James J. Harding, MD, compares the responses observed with nivolumab plus ipilimumab (NIVO + IPI) therapy in the CheckMate 9DW trial to other first-line (1L)…
“I Thought He Was Helping Me”: Patient Endured 9 Years of Chemotherapy for Cancer He Never Had
Oncologist Thomas C. Weiner misdiagnosed Anthony Olson with MDS in 2011. Olson is one of many patients who may have received unnecessary and harmful treatments…
